Article
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Nature - 1 May 2023
Pairo-Castineira Erola, Rawlik Konrad, Bretherick Andrew D, Qi Ting, Wu Yang, Nassiri Isar, McConkey Glenn A, Zechner Marie, Klaric Lucija, Griffiths Fiona, Oosthuyzen Wilna, Kousathanas Athanasios, Richmond Anne, Millar Jonathan, Russell Clark D, Malinauskas Tomas, Thwaites Ryan, Morrice Kirstie, Keating Sean, Maslove David, Nichol Alistair, Semple Malcolm G, Knight Julian, Shankar-Hari Manu, Summers Charlotte, Hinds Charles, Horby Peter, Ling Lowell, McAuley Danny, Montgomery Hugh, Openshaw Peter J M, Begg Colin, Walsh Timothy, Tenesa Albert, Flores Carlos, Riancho José A, Rojas-Martinez Augusto, Lapunzina Pablo, Yang Jian, Ponting Chris P, Wilson James F, Vitart Veronique, Abedalthagafi Malak, Luchessi Andre D, Parra Esteban J, Cruz Raquel, Carracedo Angel, Fawkes Angie, Murphy Lee, Rowan Kathy, Pereira Alexandre C, Law Andy, Fairfax Benjamin, Hendry Sara Clohisey, Baillie J Kenneth
Abstract excerpt
Critical illness in COVID-19 is an extreme and clinically homogeneous disease phenotype that we have previously shown1 to be highly efficient for discovery of genetic associations2. Despite the advanced stage of illness at presentation, we have shown that host genetics in patients who are critically ill with COVID-19 can identify immunomodulatory therapies with strong beneficial effects in this group3. Here we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.